Cubist Systematic Strategies, LLC - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 254 filers reported holding AMICUS THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$7,225,746
+445.9%
613,391
+557.6%
0.04%
+355.6%
Q4 2023$1,323,544
-36.8%
93,273
-45.9%
0.01%
-40.0%
Q3 2023$2,095,269
+496.7%
172,308
+516.4%
0.02%
+650.0%
Q2 2023$351,127
-87.0%
27,956
-88.5%
0.00%
-87.5%
Q1 2023$2,702,711
+212.4%
243,707
+243.9%
0.02%
+220.0%
Q4 2022$865,237
-9.9%
70,863
-23.0%
0.01%0.0%
Q3 2022$960,000
+312.0%
91,976
+324.2%
0.01%
+400.0%
Q2 2022$233,000
+109.9%
21,680
+85.1%
0.00%0.0%
Q1 2022$111,000
-93.3%
11,712
-91.8%
0.00%
-93.8%
Q4 2021$1,650,000
-50.5%
142,860
-59.0%
0.02%
-61.9%
Q3 2021$3,330,000
+86.7%
348,685
+88.4%
0.04%
+110.0%
Q2 2021$1,784,000
-55.5%
185,109
-54.3%
0.02%
-60.8%
Q1 2021$4,005,000
+84.5%
405,412
+331.3%
0.05%
+70.0%
Q4 2020$2,171,000
+34.3%
94,007
-17.8%
0.03%
+25.0%
Q3 2020$1,616,000
+57.0%
114,420
+67.7%
0.02%
+33.3%
Q2 2020$1,029,000
+392.3%
68,245
+201.7%
0.02%
+200.0%
Q1 2020$209,000
-79.7%
22,623
-78.6%
0.01%
-68.4%
Q4 2019$1,031,000
-62.1%
105,882
-68.8%
0.02%
-64.8%
Q3 2019$2,723,000
+533.3%
339,473
+884.7%
0.05%
+575.0%
Q2 2019$430,000
-88.7%
34,474
-87.6%
0.01%
-93.5%
Q1 2019$3,795,000
+4417.9%
279,051
+3086.2%
0.12%
+2975.0%
Q4 2018$84,000
-42.9%
8,758
-28.2%
0.00%
-50.0%
Q3 2018$147,000
+122.7%
12,190
+187.7%
0.01%
+166.7%
Q2 2018$66,000
+83.3%
4,237
+69.5%
0.00%
+50.0%
Q4 2017$36,000
-84.4%
2,500
-83.7%
0.00%
-84.6%
Q3 2017$231,000
+402.2%
15,300
+139.6%
0.01%
+333.3%
Q1 2017$46,000
+4500.0%
6,386
+4461.4%
0.00%
Q4 2016$1,000
-98.9%
140
-98.8%
0.00%
-100.0%
Q3 2016$88,000
-3.3%
11,935
-28.0%
0.01%
+20.0%
Q2 2016$91,000
-69.8%
16,587
-46.5%
0.01%
-72.2%
Q4 2015$301,000
-60.3%
31,008
-42.8%
0.02%
-52.6%
Q3 2015$758,000
+802.4%
54,169
+604.7%
0.04%
+850.0%
Q1 2015$84,000
-50.6%
7,687
-73.1%
0.00%
-60.0%
Q3 2014$170,00028,6220.01%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 1,315,395$30,372,00010.86%
Palo Alto Investors LP 7,867,114$181,652,0009.52%
Perceptive Advisors 25,112,048$579,837,0006.22%
Redmile Group, LLC 20,620,490$476,127,0005.76%
Avoro Capital Advisors LLC 9,000,000$207,810,0003.58%
Ghost Tree Capital, LLC 600,000$13,854,0003.09%
SECTORAL ASSET MANAGEMENT INC 1,534,604$35,434,0002.50%
CM Management, LLC 90,000$2,078,0001.93%
Boxer Capital, LLC 2,325,000$53,684,0001.73%
Hood River Capital Management LLC 2,204,140$50,894,0001.68%
View complete list of AMICUS THERAPEUTICS INC shareholders